Award

(NU/1433-22) ESP (Extracellular Synucleinopathic Protein) Diagnostics Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

22 Dec 2021 at 10:38

Award Notice
Summary of the contracting process

The recent procurement opportunity involves Newcastle University seeking management services for the commercialisation of university research specifically focusing on the development of a spin-out company related to ESP (Extracellular Synucleinopathic Protein) diagnostics. This project falls under the business and management consultancy services category and has an estimated value of £30,000. The contract is currently in the award stage, having been awarded on 10th December 2021. The contract will commence on 16th December 2021 and conclude on 31st March 2022. Interested parties should note that the delivery will take place in the North East region of the United Kingdom.

This contract presents a significant opportunity for businesses that specialise in consultancy services, particularly those with expertise in healthcare, management, and business planning. Small and medium-sized enterprises (SMEs) would be particularly suited to this tender as the project aims to develop a robust five-year business plan and secure venture capital funding for the start-up. Businesses with a strong background in assisting academic institutions and experience in the biotech or healthcare sectors may find this tender especially advantageous for growth and collaboration prospects.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

(NU/1433-22) ESP (Extracellular Synucleinopathic Protein) Diagnostics Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

Notice Description

Every year in the UK, around 20,000 new cases of Parkinson's disease are diagnosed along with over 20,000 new cases of Dementia with Lewy bodies (DLB), the second commonest form of dementia after Alzheimer's disease. Dementia is the biggest healthcare challenge globally, this being recognised in the UK through the Prime Minister's Challenge on Dementia 2020 and the NHS England Five Year Forward View, where improving diagnosis, treatment and care is a core focus. These neurodegenerative disorders carry a huge economic burden, in the US alone the annual costs exceed $850 billion, with this estimated to double in the next three decades. DLB is the costliest type of dementia, with patients needing more emergency care, hospitalisation, treatment, and with a greater caregiver burden. We are looking for an executive and the initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary for ERDF or Research England reporting requirements; (4) Secure (venture capital and other) funding Stage (4) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 3 above.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-c044ee84-5292-49f4-be75-053a5524c900
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/d56cee2b-8ecb-4807-94bb-6819f532fce3
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Restricted procedure
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
£30,000 Under £100K
Lots Value
Not specified
Awards Value
£24,000 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
22 Dec 20214 years ago
Submission Deadline
15 Oct 2021Expired
Future Notice Date
Not specified
Award Date
10 Dec 20214 years ago
Contract Period
16 Dec 2021 - 31 Mar 2022 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC North East (England)
Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

ATHYMETRIX

Further Information

Notice Documents

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-c044ee84-5292-49f4-be75-053a5524c900-2021-12-22T10:38:11Z",
    "date": "2021-12-22T10:38:11Z",
    "ocid": "ocds-b5fd17-c044ee84-5292-49f4-be75-053a5524c900",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "NCL001-DN568817-41099916",
        "title": "(NU/1433-22) ESP (Extracellular Synucleinopathic Protein) Diagnostics Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation",
        "description": "Every year in the UK, around 20,000 new cases of Parkinson's disease are diagnosed along with over 20,000 new cases of Dementia with Lewy bodies (DLB), the second commonest form of dementia after Alzheimer's disease. Dementia is the biggest healthcare challenge globally, this being recognised in the UK through the Prime Minister's Challenge on Dementia 2020 and the NHS England Five Year Forward View, where improving diagnosis, treatment and care is a core focus. These neurodegenerative disorders carry a huge economic burden, in the US alone the annual costs exceed $850 billion, with this estimated to double in the next three decades. DLB is the costliest type of dementia, with patients needing more emergency care, hospitalisation, treatment, and with a greater caregiver burden. We are looking for an executive and the initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary for ERDF or Research England reporting requirements; (4) Secure (venture capital and other) funding Stage (4) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 3 above.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "North East",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 30000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Restricted procedure",
        "tenderPeriod": {
            "endDate": "2021-10-15T12:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2021-12-16T00:00:00Z",
            "endDate": "2022-03-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-59869",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Natalie Morton",
                "email": "natalie.morton@ncl.ac.uk",
                "telephone": "+44 1912086396"
            },
            "details": {
                "url": "https://www.ncl.ac.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-193074",
            "name": "Athymetrix Ltd",
            "identifier": {
                "legalName": "Athymetrix Ltd"
            },
            "address": {
                "streetAddress": "45 Norham Drive Morpeth Northumberland NE61 2XA United Kingdom"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-59869",
        "name": "Newcastle University"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-c044ee84-5292-49f4-be75-053a5524c900-1",
            "status": "active",
            "date": "2021-12-10T00:00:00Z",
            "datePublished": "2021-12-22T10:38:11Z",
            "value": {
                "amount": 24000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-193074",
                    "name": "Athymetrix Ltd"
                }
            ],
            "contractPeriod": {
                "startDate": "2021-12-16T00:00:00Z",
                "endDate": "2022-03-31T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/d56cee2b-8ecb-4807-94bb-6819f532fce3",
                    "datePublished": "2021-12-22T10:38:11Z",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}